Literature DB >> 3500718

Tissue specificity and developmental expression of rat osteopontin.

K Yoon1, R Buenaga, G A Rodan.   

Abstract

Osteopontin is a 44 kd phosphoprotein abundant in bone matrix. We isolated a partial length cDNA for rat osteopontin and used it to examine its tissue specificity, its expression during bone development and its hormonal regulation. Osteopontin mRNA is most abundant in bone but is also found in considerable amounts in kidney. Osteopontin mRNA is regulated by the osteotropic hormones dexamethasone and 1,25(OH)2D3. Estimates of osteopontin mRNA levels indicate that the osteopontin gene is turned on relatively late in calvarial development.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3500718     DOI： 10.1016/s0006-291x(87)80250-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  44 in total

Review 1.  Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization.

Authors:  J P Gorski
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

2.  Enhanced in vivo responses of osteoblasts in electrostatically activated zones by hydroxyapatite electrets.

Authors:  Satoshi Nakamura; Takayuki Kobayashi; Miho Nakamura; Kimihiro Yamashita
Journal:  J Mater Sci Mater Med       Date:  2008-08-14       Impact factor: 3.896

3.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

4.  Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation.

Authors:  S I Dworetzky; E G Fey; S Penman; J B Lian; J L Stein; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Modifications of protein-DNA interactions in the proximal promoter of a cell-growth-regulated histone gene during onset and progression of osteoblast differentiation.

Authors:  T A Owen; J Holthuis; E Markose; A J van Wijnen; S A Wolfe; S R Grimes; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

Authors:  C M Shanahan; N R Cary; J C Metcalfe; P L Weissberg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

7.  Gene expression and distribution of key bone turnover markers in the callus of estrogen-deficient, vitamin D-depleted rats.

Authors:  Gunhild Melhus; S H Brorson; E S Baekkevold; G Andersson; R Jemtland; O K Olstad; F P Reinholt
Journal:  Calcif Tissue Int       Date:  2010-05-22       Impact factor: 4.333

8.  Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).

Authors:  R Pichler; C M Giachelli; D Lombardi; J Pippin; K Gordon; C E Alpers; S M Schwartz; R J Johnson
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice.

Authors:  Amelia L M Sutton; Xiaoxue Zhang; Diane R Dowd; Yogendra P Kharode; Barry S Komm; Paul N Macdonald
Journal:  Mol Endocrinol       Date:  2008-03-20

10.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.